These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 3110629)

  • 21. The subtype of serotonin (5-HT) receptors in the rat pulmonary artery.
    Uma S; Tuncer M; Kayaalp SO
    Arch Int Pharmacodyn Ther; 1987 Aug; 288(2):248-55. PubMed ID: 3675084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of rat neocortical high-voltage spindle activity by 5-HT1/5-HT2 receptor subtype specific drugs.
    Jäkälä P; Sirviö J; Koivisto E; Björklund M; Kaukua J; Riekkinen P
    Eur J Pharmacol; 1995 Aug; 282(1-3):39-55. PubMed ID: 7498288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of 5-hydroxytryptamine on human isolated placental chorionic arteries and veins.
    Reviriego J; Marín J
    Br J Pharmacol; 1989 Apr; 96(4):961-9. PubMed ID: 2743086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of cardiovascular and smooth muscle effects of 5-hydroxytryptamine and 5-carboxamidotryptamine, a selective agonist of 5-HT1 receptors.
    Saxena PR; Lawang A
    Arch Int Pharmacodyn Ther; 1985 Oct; 277(2):235-52. PubMed ID: 2933009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Yohimbine and rauwolscine inhibit 5-hydroxytryptamine-induced contraction of large coronary arteries of calf through blockade of 5 HT2 receptors.
    Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Jun; 323(2):149-54. PubMed ID: 6136920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quipazine reduces food intake in the rat by activation of 5-HT2-receptors.
    Hewson G; Leighton GE; Hill RG; Hughes J
    Br J Pharmacol; 1988 Oct; 95(2):598-604. PubMed ID: 2906561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variable participation of 5-HT1-like receptors and 5-HT2 receptors in serotonin-induced contraction of human isolated coronary arteries. 5-HT1-like receptors resemble cloned 5-HT1D beta receptors.
    Kaumann AJ; Frenken M; Posival H; Brown AM
    Circulation; 1994 Sep; 90(3):1141-53. PubMed ID: 8087924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ketanserin causes surmountable antagonism of 5-hydroxytryptamine-induced contractions of large coronary arteries of dog.
    Frenken M; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jan; 328(3):301-3. PubMed ID: 3157065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [3H]ketanserin binds to non-5-HT2 sites in rabbit cerebral cortex and neostriatum.
    Dewar KM; Lima L; Reader TA
    Neurochem Res; 1990 May; 15(5):507-14. PubMed ID: 2115148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-hydroxytryptamine antagonistic effects of ICI 169,369, ICI 170,809 and methysergide in human temporal and cerebral arteries.
    Jansen I; Blackburn T; Eriksen K; Edvinsson L
    Pharmacol Toxicol; 1991 Jan; 68(1):8-13. PubMed ID: 2008418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
    Ellwood AJ; Curtis MJ
    Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Actions of non-peptide ergot alkaloids at 5-HT1-like and 5-HT2 receptors mediating vascular smooth muscle contraction.
    MacLennan SJ; Martin GR
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Aug; 342(2):120-9. PubMed ID: 2234096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolongation of rat tail bleeding time by ketanserin: mechanisms of action.
    Buczko W; Gambino MC; De Gaetano G
    Eur J Pharmacol; 1984 Aug; 103(3-4):261-8. PubMed ID: 6237923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of U46619 on contractions to 5-HT, sumatriptan and methysergide in canine coronary artery and saphenous vein in vitro.
    Kemp BK; Cocks TM
    Br J Pharmacol; 1995 Oct; 116(4):2183-90. PubMed ID: 8564247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential antagonism of the initial fast and secondary slow contractile responses of the rat isolated aorta to 5-hydroxytryptamine by mianserin and ketanserin.
    Doggrell SA
    J Auton Pharmacol; 1987 Jun; 7(2):157-64. PubMed ID: 3654683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potentiation of responses to sympathetic nerve stimulation and vasoconstrictor agents by SK&F 103829 in the feline mesenteric circulation.
    Taylor EM; Kaumann AJ
    Br J Pharmacol; 1994 Jan; 111(1):264-70. PubMed ID: 8012704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduction in opioid and non-opioid forms of swim analgesia by 5-HT2 receptor antagonists.
    Kiefel JM; Paul D; Bodnar RJ
    Brain Res; 1989 Oct; 500(1-2):231-40. PubMed ID: 2605492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Behavioural evidence for a functional interaction between central 5-HT2 and 5-HT1A receptors.
    Backus LI; Sharp T; Grahame-Smith DG
    Br J Pharmacol; 1990 Aug; 100(4):793-9. PubMed ID: 2145051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of chronic ritanserin and clorgyline administration on 5-HT2 receptor linked inositol phospholipid hydrolysis.
    Twist EC; Brammer MJ; Stephenson JD; Corn TH; Campbell IC
    Biochem Pharmacol; 1990 Nov; 40(9):2111-6. PubMed ID: 2122900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the heart rate effects of 5-hydroxytryptamine in the cat; mediation of tachycardia by 5-HT1-like receptors.
    Saxena PR; Mylecharane EJ; Heiligers J
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Aug; 330(2):121-9. PubMed ID: 2931607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.